S. 1221 · 111th Congress
A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs…
Full title
A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
SpecterSponsor10 cosponsors · 6 D, 4 R
R
Roberts
BL
D
Lincoln
SB
D
Brown
RB
R
Bennett
FL
D
Lautenberg
BC
D
Casey
LA
R
Alexander
RB
R
Burr
DS
D
Stabenow
KH
D
Hagan1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
What it does: CRS summary · Introduced in Senate · Jun 9, 2009
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Latest action (Jun 9, 2009): Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
Policy area: Health · Origin: Senate · Introduced: Jun 9, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.